Silo Pharma, Inc. (SILO) vs Alaunos Therapeutics, Inc. (TCRT)

Silo Pharma, Inc. and Alaunos Therapeutics, Inc. are both Biotechnology companies. Silo Pharma, Inc. and Alaunos Therapeutics, Inc. are of similar size ($2.9M and $2.8M). Silo Pharma, Inc. grew revenue faster over the last twelve months: 0.00% against −17.7%. Across the 14 metrics below, Silo Pharma, Inc. leads on 10 and Alaunos Therapeutics, Inc. on 4.

Valuation

Metric SILO TCRT Biotechnology median
P/E n/m n/m 7.88
P/S 26.69 189.35 11.47
P/B 0.39 4.07 2.52
Price to free cash flow n/m n/m 21.16
EV/EBITDA 0.76 n/m 0.74
EV/Sales (45.86) 264.13 10.73
Earnings yield (249.04%) (175.23%) (28.84%)
Free cash flow yield (204.00%) (49.83%) (23.03%)

Profitability

Metric SILO TCRT Biotechnology median
Gross margin 11.81% 100.00% 65.16%
Operating margin 0.00% 0.00% 0.00%
Net margin 0.00% 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity (91.23%) (185.95%) (57.72%)
Return on assets (70.96%) (128.30%) (49.22%)
Return on invested capital 0.00% (480.35%) 0.00%

Growth

Metric SILO TCRT Biotechnology median
Revenue growth (TTM) 0.00% (17.65%) 5.64%
EPS growth (last fiscal year) 57.98% 24.66% —
Revenue growth, 5-year CAGR 12.17% (49.08%) 8.40%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric SILO TCRT Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 5.36 0.77 4.73
Net debt to EBITDA 1.61 0.33 0.96

Dividend

Metric SILO TCRT Biotechnology median
Dividend yield — — 2.10%
Payout ratio — 0.00 0.00

Size

Metric SILO TCRT Biotechnology median
Market cap 2.78m 2.87m 162.10m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack